Imaging Young Myeloma (IMAgerie JEune Myélome)

Details

Instance of

clinical trial

Start time

February 2011

End time

September 2013

Country

France

Main subject

positron emission tomography, multiple myeloma

clinical trial phase

phase III clinical trial

maximum age

65

minimum age

18

number of participants

152

research site

University of Bordeaux, Rangueil Hospital

short name

IMAJEM

study type

interventional study

title

Pharmacoeconomic and Clinical Prospective Comparison of PET-scan and MRI in Patients With de Novo Multiple Myeloma Less Than 65 Years of Age Treated According to IFM/DFCI 2009 Clinical Trial.